These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34652111)

  • 1. Onychomycosis: Rapid Evidence Review.
    Frazier WT; Santiago-Delgado ZM; Stupka KC
    Am Fam Physician; 2021 Oct; 104(4):359-367. PubMed ID: 34652111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onychomycosis: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL; Barankin B; Leung AAM; Wong AHC
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):32-45. PubMed ID: 31738146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
    Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
    J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.
    Gupta AK; Versteeg SG; Shear NH
    J Cutan Med Surg; 2018; 22(2):129-141. PubMed ID: 28954534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis: a review.
    Gupta AK; Stec N; Summerbell RC; Shear NH; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1972-1990. PubMed ID: 32239567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of current therapies for onychomycosis.
    Ricardo JW; Lipner SR
    Expert Opin Drug Saf; 2020 Nov; 19(11):1395-1408. PubMed ID: 32990062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis in the elderly : drug treatment options.
    Loo DS
    Drugs Aging; 2007; 24(4):293-302. PubMed ID: 17432924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efinaconazole and Tavaborole.
    Poulakos M; Grace Y; Machin JD; Dorval E
    J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
    Gupta AK; Surprenant MS; Kempers SE; Pariser DM; Rensfeldt K; Tavakkol A
    J Am Acad Dermatol; 2021 Jul; 85(1):95-104. PubMed ID: 32585278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis.
    Mikailov A; Cohen J; Joyce C; Mostaghimi A
    JAMA Dermatol; 2016 Mar; 152(3):276-81. PubMed ID: 26716567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
    Gupta AK; Stec N; Bamimore MA; Foley KA; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):580-588. PubMed ID: 31746067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal nail infections: diagnosis and management.
    Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on tavaborole for the treatment of onychomycosis.
    Jinna S; Finch J
    Drug Des Devel Ther; 2015; 9():6185-90. PubMed ID: 26640371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
    Wang Y; Lipner SR
    Arch Dermatol Res; 2020 Oct; 312(8):581-586. PubMed ID: 32076805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efinaconazole in Onychomycosis.
    Gupta AK; Talukder M
    Am J Clin Dermatol; 2022 Mar; 23(2):207-218. PubMed ID: 34902110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.